Lysosomes
DOI: 10.1007/0-387-28957-7_8
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal Ceroid-Lipofuscinoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 120 publications
0
5
0
Order By: Relevance
“…Subunit c of ATP synthase is a component of ceroid lipofuscin that accumulates in neurons of patients suffering from a subclass of ceroid lipofuscinoses, a group of fatal neurodegenerative diseases. 83,84 In humans, this disease subclass is caused by mutations in CLN genes (numbers 2, 3, 4, 5, 6, 7 and 8), encoding either the lysosomal enzyme tripeptidyl peptidase I, or a group of novel lysosomal membrane proteins. The rest of neuronal ceroid lipofucsinoses are caused by mutations in the CLN1 gene, encoding the enzyme palmitoyl protein thioesterase.…”
Section: Regulation Of the Fusion Eventsmentioning
confidence: 99%
“…Subunit c of ATP synthase is a component of ceroid lipofuscin that accumulates in neurons of patients suffering from a subclass of ceroid lipofuscinoses, a group of fatal neurodegenerative diseases. 83,84 In humans, this disease subclass is caused by mutations in CLN genes (numbers 2, 3, 4, 5, 6, 7 and 8), encoding either the lysosomal enzyme tripeptidyl peptidase I, or a group of novel lysosomal membrane proteins. The rest of neuronal ceroid lipofucsinoses are caused by mutations in the CLN1 gene, encoding the enzyme palmitoyl protein thioesterase.…”
Section: Regulation Of the Fusion Eventsmentioning
confidence: 99%
“…Sleep questionnaires were obtained for the patients under 20 years of age (mean age 14 years). Questionnaire data were not available for the four older patients in an advanced stage of the disease (age range [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]…”
Section: Polysomnographymentioning
confidence: 99%
“…They share common clinical features including visual failure leading to blindness, seizures, myoclonic epilepsies, and progressive mental and motor deterioration (Santavuori et al 2001). NCLs are characterized by massive lysosomal storage of autofluorescent ceroid and lipofuscin as well as aggregated proteins such as subunit c of the mitochondrial ATP synthase or sphingolipid activator proteins (Tyynelä 2005). Currently, seven human NCL genes have been identified.…”
Section: Introductionmentioning
confidence: 99%